We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




PET/CT Improves Assessment of Oesophageal Malignancy

By MedImaging International staff writers
Posted on 03 Feb 2015
Print article
Esophageal carcinoma is the eighth most common cancer globally. It occurs in the inside lining of the esophagus, and is diagnosed by biopsy using Endoscopic Ultrasound (EUS). Treatment includes surgery, chemotherapy, radiotherapy, or palliative care. Radiotherapy is often used for both curative and palliative treatment. The outcomes of treatment are often poor because of late diagnosis, and can result in a 5-year survival rate of only 13%‒18%.

Now a new study has shown that Positron Emission Tomography/Computed Tomography (PET/CT) could be used for planning radiotherapy, surgical resection, and other treatments. The researchers assessed 53 patients who had been treated with PET/CT, EUS, Esophago-gastroduodenoscopy (OGD), and surgical resection for esophageal cancer. Tumor length was assessed retrospectively. For EUS and OGD direct measurements were made.

Results of the study showed that estimating the histopathological length of the tumor using PET/CT was the most accurate method, when compared to direct measurements by EUS. Measurements using OGD were the least accurate method.

The research team was led by Dr. K. Rollins of the Esophago-Gastric Surgery department at Nottingham University Hospitals (Nottingham, United Kingdom). The results of the study will be published in the February 2015 issue of European Journal of Radiology.

Related Links:

Nottingham University Hospitals



Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Silver Member
Mobile X-Ray Barrier
Lead Acrylic Mobile X-Ray Barriers
New
X-Ray Detector
FDR-D-EVO III
New
C-Arm with FPD
Digiscan V20 / V30

Print article

Channels

Radiography

view channel
:	Image: The AI model could be a valuable adjunct to human radiologists in breast cancer diagnoses and risk prediction (Photo courtesy of 123RF)

AI Model Predicts 5-Year Breast Cancer Risk from Mammograms

Approximately 13% of U.S. women, or one in every eight, are predicted to develop invasive breast cancer over their lifetime, with 1 in 39 women (3%) succumbing to the illness, according to the American... Read more

General/Advanced Imaging

view channel
Image: The CIARTIC Move self-driving mobile C-arm has received FDA clearance (Photo courtesy of Siemens)

Self-Driving Mobile C-Arm Reduces Imaging Time during Surgery

Intraoperative imaging faces significant challenges due to staff shortages and the high demands placed on surgical teams in the operating room (OR). A common challenge during many OR procedures is the... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.